Antidepressant Reboxetine ineffective: Review By Dr Ananya Mandal.

They discovered that isolated trials which have been published and reviews of the info in the public domain possess all shown the medication to be effective. But the German institute’s scientists found that eight out of 13 significant trials had not seen the light of time. Pfizer had provided data from 1,600 patients only but trials included 4,600. Today the institute accuses the producers of publishing only positive results for the medication. Robert Steinbrook from Dartmouth and Yale and Jerome Kassirer from Tufts University institutions of medicine in the US in another commentary state that there were recent controversies of equivalent nature related to drugs like Avandia for diabetes and the painkiller Vioxx that acquired safety problems.The restlessness is recognised by them, anxiety, nervousness and palpitations.

CMS officials concentrate on health care innovation At yesterday’s ‘Summit,’ officials from the Centers for Medicare and Medicaid Services advanced the idea that finding new ways to improve quality of care is also the easiest method to address high health care costs. Modern Health care: CMS’ Gilfillan: Period For Innovation Commitment IS CURRENTLY A top CMS official urged company leaders, including hospital executives, to attempt the technology-driven changes in their systems that they wish will improve treatment and lower costs.